University of Birmingham set for renewal of pioneering Cancer Research Clinical Trials Unit which delivers more than 100 national and international trials
The Sarkar and Barrett labs have defined the molecular basis of neurodegeneration in Wolfram Syndrome patients carrying the WFS1 gene mutation.
NHS Cancer Programme funding will see an advanced test used at GP surgeries in the West Midlands to diagnose early-stage ovarian cancer.
Patients with aggressive brain tumours may be able to take part in a new trial of a cannabinoid-based drug, coordinated by the University of Birmingham.
Study showed that low levels of the MYB protein can be linked to the development of rare blood cancers.
Hypertension patients could receive a personalised medication profile thanks to a new, artificial intelligence-supported research project.
Cancer Research UK Clinical Trials Unit-sponsored trial found new drug better for treating rare cancer for patients not responding to first line treatment
Research has major implications for neurodegenerative disease treatments
Children with some tumours may benefit from receiving a combination of inhibitor drugs, according to interim results of research presented at a conference.
A multi-centre trial, led by Professor Andrew Peet, has shown measuring brain tumour blood supply in children can indicate tumours that may be more aggressive.